Ironwood Pharmaceuticals Inc (IRWD)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -12.297 | -17.778 | -60.224 | 5.853 | 22.074 | 62.68 | 15.719 | -127.544 |
Return on Equity (%) | -100.973 | -305.462 | 302.77 | -14.85 | -693.711 | 158.088 | 27.826 | -654.881 |
Return on Invested Capital (%) | -15.847 | -24.504 | -38.206 | 62.85 | 39.767 | 107.899 | 26.389 | -300.846 |
Operating Margin (%) | -15.533 | -27.011 | -70.576 | 22.302 | 35.515 | 56.025 | 63.327 | -209.254 |
Net Profit Margin (%) | -29.825 | -39.204 | -81.459 | 5.02 | 27.258 | 127.721 | 42.637 | -226.374 |
Book Value Per Share | -0.341 | -0.501 | -0.638 | -0.301 | 0.199 | 1.915 | 2.115 | -1.127 |
Earnings Per Share | -0.278 | -0.389 | -0.914 | 0.069 | 0.337 | 1.67 | 0.568 | -3.227 |
Cash Per Share | 0.184 | 0.418 | 0.561 | 0.567 | 1.151 | 1.96 | 2.127 | 0.297 |
Working Capital Per Share | 0.982 | 0.816 | 0.476 | 0.852 | 1.472 | 1.844 | 2.448 | -0.138 |
Operating Profit Per Share | 0.923 | 1.032 | 1.137 | 1.326 | 1.234 | 1.308 | 1.331 | 1.426 |
EBIT Per Share | -0.278 | -0.389 | -0.914 | 0.189 | 0.346 | 0.634 | 0.818 | -3.053 |
EBITDA Per Share | -0.278 | -0.389 | -0.914 | 0.189 | 0.346 | 0.634 | 0.818 | -3.053 |
Free Cash Flow Per Share | -0.302 | -0.423 | -0.932 | 0.074 | 0.336 | 1.666 | 0.563 | -3.23 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 132,63M | 136,47M | 154,42M | 157,54M | 160,62M | 162,04M | 154,03M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 153,32M | 154,03M | N/A | 156,03M | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | 64.758 | N/A | N/A | N/A | 16.279 | N/A |
Net Profit Margin (%) | N/A | N/A | 43.93 | N/A | N/A | N/A | -5.558 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 595,31M |
Ratio cours/bénéfice | -0,59 |
Ratio prix/ventes | 1,33 |
Ratio prix/liquidités | 6,39 |
Ratio prix/valeur comptable | -1,7 |
Rendement de dividende | - |
Actions en circulation | 160,03M |
Volume moyen (1 semaine) | 2,04M |
Volume moyen (1 mois) | 1,74M |
Variation sur 52 semaines | -64,62% |
Plus haut sur 52 semaines | 15,70 |
Plus bas sur 52 semaines | 3,06 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales